Date Name Title Filing Type Shares Traded Price Total Held
Sep 17, 2003
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Open market or private sale of non-derivative or derivative security 500 $20.28 107,551
Nov 22, 2019
Director, Chairman of the Board
Director, Chairman of the Board Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 46,138 -- 107,655
Sep 17, 2003
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Open market or private sale of non-derivative or derivative security 3,200 $20.27 108,051
May 01, 2013
Director, President & CEO
Director, President & CEO Form 4 Open market or private sale of non-derivative or derivative security 400 $235.75 108,315
Dec 16, 2014
Director, Chairman of the Board
Director, Chairman of the Board Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 108,380 -- 108,380
May 20, 2013
SVP Finance and Admin CFO and
SVP Finance and Admin CFO and Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 50,000 $21.25 108,592
Sep 19, 2013
Director, President & CEO
Director, President & CEO Form 4 Open market or private sale of non-derivative or derivative security 36,334 $300.33 108,702
May 01, 2013
Director, President & CEO
Director, President & CEO Form 4 Open market or private sale of non-derivative or derivative security 5,000 $233.34 108,715
Feb 14, 2012
SVP Research and Development S
SVP Research and Development S Form 4 Open market or private sale of non-derivative or derivative security 2,350 $108.60 108,722
Jan 31, 2012
SVP Finance and Admin CFO Trea
SVP Finance and Admin CFO Trea Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 6,334 $90.07 108,856

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.